News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Defense Advanced Research Projects Agency Grants $23 Million Contract to Battelle, NxStage Medical, Inc. (NXTM) and Aethlon Medical (AEMD) for a Sepsis Treatment


7/25/2013 7:52:00 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Battelle, NxStage and Aethlon will collaborate on a mobile medical device to treat sepsis in soldiers, funded by a $23M contract with DARPA. The U.S. Defense Advanced Research Projects Agency (DARPA) handed a $23 million contract to 3 companies, Battelle, NxStage (NSDQ:NXTM) and Aethlon (OTC:AEMD), who will collaborate on a sepsis treatment device for the military. The project, which DARPA is calling the Dialysis-Like Therapeutics (DLT) program, will be funded in phases and the companies are tasked with building a portable sepsis treatment device.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at News Release
Read at Boston Globe
Read at Columbus Dispatch

comments powered by Disqus
   
Sepsis

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES